rs144175566
Variant summary
Our verdict is Benign. Variant got -20 ACMG points: 0P and 20B. BP4_StrongBP6_Very_StrongBS1BS2
The NM_001039141.3(TRIOBP):c.4165C>A(p.Leu1389Ile) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0011 in 1,609,754 control chromosomes in the GnomAD database, including 16 homozygotes. In-silico tool predicts a benign outcome for this variant. 13/19 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Benign (★★).
Frequency
Consequence
NM_001039141.3 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Benign. Variant got -20 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
TRIOBP | NM_001039141.3 | c.4165C>A | p.Leu1389Ile | missense_variant | 9/24 | ENST00000644935.1 | NP_001034230.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
TRIOBP | ENST00000644935.1 | c.4165C>A | p.Leu1389Ile | missense_variant | 9/24 | NM_001039141.3 | ENSP00000496394 | A2 | ||
TRIOBP | ENST00000344404.10 | c.*3648C>A | 3_prime_UTR_variant, NMD_transcript_variant | 7/22 | 2 | ENSP00000340312 |
Frequencies
GnomAD3 genomes AF: 0.00579 AC: 881AN: 152154Hom.: 6 Cov.: 32
GnomAD3 exomes AF: 0.00133 AC: 317AN: 239056Hom.: 1 AF XY: 0.00104 AC XY: 136AN XY: 130824
GnomAD4 exome AF: 0.000606 AC: 883AN: 1457482Hom.: 10 Cov.: 36 AF XY: 0.000541 AC XY: 392AN XY: 724754
GnomAD4 genome AF: 0.00581 AC: 885AN: 152272Hom.: 6 Cov.: 32 AF XY: 0.00571 AC XY: 425AN XY: 74446
ClinVar
Submissions by phenotype
not specified Benign:2
Benign, criteria provided, single submitter | clinical testing | Laboratory for Molecular Medicine, Mass General Brigham Personalized Medicine | Apr 30, 2012 | Leu1389Ile in Exon 09 of TRIOBP: This variant is not expected to have clinical s ignificance because it has been identified in 1.7% (53/3102) of African American chromosomes from a broad population by the NHLBI Exome Sequencing Project (http ://evs.gs.washington.edu/EVS; dbSNP rs144175566). - |
Benign, criteria provided, single submitter | clinical testing | PreventionGenetics, part of Exact Sciences | - | - - |
not provided Benign:2
Benign, criteria provided, single submitter | clinical testing | GeneDx | Feb 26, 2019 | - - |
Benign, criteria provided, single submitter | clinical testing | Labcorp Genetics (formerly Invitae), Labcorp | Jan 29, 2024 | - - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at